Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sorafenib in Treating Patients With Advanced Solid Tumors

This study has been terminated.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: February 15, 2007
Last updated: February 21, 2014
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)